-
Three Key Challenges for Wide-Scale AI Adoption in Pharma
contractpharma
April 15, 2019
Loubna Bouarfa of OKRA Technologies discusses how to transform the challenges into tremendous opportunity...
-
FDA lays out plans for a new review framework for AI and machine learning-based devices
fiercepharma
April 04, 2019
The FDA has begun to reconsider how it reviews and approves medical devices that employ artificial intelligence and to learn from data to adapt their care.
-
Standigm raises $11.5M in Series B Round
biospectrumasia
April 02, 2019
Standigm will use the funds to scale the AI technology platforms and advance its drug discovery pipelines toward license-out
-
Shimadzu incorporates AI in new chromatograph series
biospectrumasia
March 18, 2019
Shimadzu's new Nexera UHPLC series with AI and IoT enhancements sets industry standard for intelligence, efficiency and design.
-
Project launched to tackle lab inefficiency, support AI adoption
europeanpharmaceuticalreview
March 13, 2019
A project backed by major pharma will advance the Lab of the Future with proof of concept software to digitise experiment methods…
-
Lucence Diagnostics to Develop AI Tools for Liver Cancer Treatment
en-cphi.cn
March 12, 2019
Lucence Diagnostics, a genomic medicine company focused on personalizing cancer care, today announced a new project to develop AI algorithms for improving diagnosis and treatment of liver cancer.
-
IBM Watson Health Invests in Research Collaborations to Advance AI to Health
americanpharmaceuticalreview
February 15, 2019
IBM Watson Health announced plans to make a 10-year, $50 million investment in research collaborations with two separate academic centers - Brigham and Women's Hospital....
-
NHS should invest in digital, AI, and robotics training
pharmaphorum
February 13, 2019
The Topol Review of the training needs of the future NHS workforce has published its recommendations – including an increase in the number of clinicians trained to use digital, AI and robotics technologies.
-
A healthy 2019: Four paws for more relaxation and exercise
worldpharmanews
January 24, 2019
Pets spend their whole lives at their owners' sides, keeping them active and comforting them in times of illness or loneliness.
-
Novartis and University of Oxford partner on AI-based drug development
pharmaceutical-technology
January 22, 2019
Novartis has partnered with the University of Oxford’s Big Data Institute (BDI) to boost drug development using artificial intelligence (AI) and advanced analytics.....